NW
GILD icon

NewEdge Wealth’s Gilead Sciences GILD Stock Holding History

NewEdge Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$98.5M Buy
706,725
+60,255
+9% +$8.44M 1.17% 14
2025
Q4 		$79.3M Buy
646,470
+26,780
+4% +$3.25M 0.9% 17
2025
Q3 		$76M Buy
619,690
+17,284
+3% +$1.96M 1.09% 12
2025
Q2 		$66.4M Buy
602,406
+170,165
+39% +$18.1M 1.04% 15
2025
Q1 		$48.4M Buy
432,241
+27,424
+7% +$2.83M 0.88% 21
2024
Q4 		$37.4M Buy
404,817
+30,243
+8% +$2.72M 0.65% 36
2024
Q3 		$31.4M Buy
374,574
+4,087
+1% +$312K 0.57% 42
2024
Q2 		$25.4M Sell
370,487
-6,943
-2% -$463K 0.55% 47
2024
Q1 		$24.7M Buy
377,430
+37,463
+11% +$2.88M 0.55% 44
2023
Q4 		$27.5M Buy
339,967
+27,572
+9% +$2.15M 0.7% 34
2023
Q3 		$23.4M Buy
312,395
+47,137
+18% +$3.63M 0.74% 32
2023
Q2 		$20.4M Buy
265,258
+81,231
+44% +$6.48M 0.68% 34
2023
Q1 		$15.3M Buy
184,027
+97,736
+113% +$8.09M 0.58% 49
2022
Q4 		$7.41M Buy
86,291
+3,874
+5% +$307K 0.32% 89
2022
Q3 		$5.08M Sell
82,417
-23,415
-22% -$1.48M 0.24% 101
2022
Q2 		$6.54M Buy
105,832
+33,126
+46% +$2.05M 0.3% 87
2022
Q1 		$4.32M Buy
72,706
+6,129
+9% +$392K 0.19% 117
2021
Q4 		$4.83M Buy
66,577
+5,011
+8% +$345K 0.2% 112
2021
Q3 		$4.3M Buy
+61,566
New +$4.33M 0.26% 90

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

NewEdge Wealth's GILD Position: Q1 2026 in Review

NewEdge Wealth increased its Gilead Sciences (GILD) stake by 9.3% in Q1 2026, buying an estimated $8.44M and bringing the position to 706,725 shares worth $98.5M. The position accounts for 1.17% of the portfolio, ranked #14.

NewEdge Wealth first reported a position in GILD in Q3 2021 and has held it in 19 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • NewEdge Wealth held 706,725 shares of Gilead Sciences worth $98.5M as of Q1 2026.
  • NewEdge Wealth bought 60,255 Gilead Sciences shares in Q1 2026, an estimated $8.44M.
  • Gilead Sciences made up 1.17% of NewEdge Wealth's portfolio in Q1 2026, its #14 holding.
  • NewEdge Wealth first reported a position in Gilead Sciences in Q3 2021 and has held it in 19 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on NewEdge Wealth's 13F filing for Q1 2026, filed 13 May 2026.